Case Reports in Ophthalmological Medicine (Jan 2021)

Conjunctival Tarsal Actinic Keratosis Treated with Interferon Alfa-2b: A Rare Case Report and Literature Review

  • Mónica Gimeno-Carrero,
  • María-Jesús Suárez-Fernández,
  • Beatriz Alonso-Martín,
  • Almudena de-Pablo-Cabrera,
  • María-Concepción Garrido-Ruíz,
  • Enrique Mencía-Gutiérrez

DOI
https://doi.org/10.1155/2021/6616021
Journal volume & issue
Vol. 2021

Abstract

Read online

Conjunctival neoplasia is one of the most frequent tumors in the eye. Actinic keratosis (AK) or solar keratosis is a precancerous lesion that is included with other epithelial tumors. This alteration does not break the basal membrane. There is enough evidence of successful outcomes to consider interferon alfa-2b (IFN alfa-2b) as the first choice of treatment for this type of tumors. In addition, side effects are mild and uncommon. We report a case in an 83-year-old woman who was referred to evaluate a leukoplakia in the tarsal conjunctiva of the lower left eyelid that measured 1 cm in diameter. Pathological study revealed AK. After the INF alfa-2b treatment, we observed conjunctival hyperemia, noninfiltrated upper nasal de-epithelization, and inferior nasal bulla. AK with presentation in conjunctiva is rarely described and in tarsal conjunctiva is exceptional. It is the first case published with only tarsal conjunctiva affectation.